Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages

  Sperveslage, Jan ^a   Frank, Sunna ^b   Heneweer, Carola ^b   Egberts, Jan ^b   Schniewind, Bodo ^b   Buchholz, Malte ^c   Bergmann, Frank ^d   Giese, Nathalia ^d   Munding, Johanna ^e   Hahn, Stephan A ^e   Kalthoff, Holger ^b   Klöppel, Günter ^b,f   Sipos, Bence ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

CCL19; CCL21; CCR7; lymph node metastasis; lymphatic spread; pancreatic ductal adenocarcinoma

Indexed keywords

CHEMOKINE RECEPTOR CCR7; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MESSENGER RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MICRODISSECTION; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CHEMOKINE CCL19; CHEMOKINE CCL21; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CCR7;

EID: 84862546400     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26502     Document Type: Article

References (25)

1. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-10. (Pubitemid 38339364)
2. Sipos B, Kojima M, Tiemann K, Klapper W, Kruse ML, Kalthoff H, Schniewind B, Tepel J, Weich H, Kerjaschki D, Kloppel G,. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J Pathol 2005; 207: 301-12. (Pubitemid 41556454)
3. Schneider M, Buchler P, Giese N, Giese T, Wilting J, Buchler MW, Friess H,. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. Int J Oncol 2006; 28: 883-90.
4. Ben-Baruch A,. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 2006; 25: 357-71. (Pubitemid 44922355)
5. Zlotnik A,. Chemokines and cancer. Int J Cancer 2006; 119: 2026-9. (Pubitemid 44423657)
6. Cyster JG,. Chemokines and cell migration in secondary lymphoid organs. Science 1999; 286: 2098-102. (Pubitemid 129516279)
7. Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF, Stingl G, Kerjaschki D, Maurer D,. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001; 194: 797-808. (Pubitemid 32983015)
8. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M,. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23-33. (Pubitemid 29468627)
9. Sipos B, Moser S, Kalthoff H, Torok V, Lohr M, Kloppel G,. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 2003; 442: 444-52. (Pubitemid 36718311)
10. Sipos B, Weber D, Ungefroren H, Kalthoff H, Zuhlsdorff A, Luther C, Torok V, Kloppel G,. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study. Int J Cancer 2002; 102: 592-600. (Pubitemid 35334466)
11. Sipos B, Klapper W, Kruse ML, Kalthoff H, Kerjaschki D, Kloppel G,. Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol 2004; 165: 1187-97. (Pubitemid 39297725)
12. Tepel J, Kruse ML, March C, Fiedler A, Kapischke M, Ketterer T, Sipos B, Kremer B, Kalthoff H,. Terminally modified oligodeoxynucleotides directed against p53 in an orthotopic xenograft model: a novel adjuvant treatment strategy for pancreatic ductal carcinoma. Pancreas 2004; 28: 1-12. (Pubitemid 38032238)
13. International Union Against Cancer (UICC). Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th edn. New York: Wiley-Liss, 2002.
14. Klöppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ,. Ductal adenocarcinoma of the pancreas. In:, Hamilton SR, Aaltonen LA, eds. Pathology and genetics of tumours of the digestive system. WHO classification of tumours. Lyon: IARC Press, 2000.
15. Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA,. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res 2009; 69: 349-57.
16. Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R,. The use of 3-D cultures for high-throughput screening: the multicellular spheroid model. J Biomol Screen 2004; 9: 273-85.
17. Li Y, Qiu X, Zhang S, Zhang Q, Wang E,. Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2α correlates with migration and invasion in lung cancer cells. Cancer Biol Ther 2009; 8: 322-30.
18. Meijer J, Zeelenberg IS, Sipos B, Roos E,. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. Cancer Res 2006; 66: 9576-82. (Pubitemid 44623656)
19. Shields JD, Emmett MS, Dunn DB, Joory KD, Sage LM, Rigby H, Mortimer PS, Orlando A, Levick JR, Bates DO,. Chemokine-mediated migration of melanoma cells towards lymphatics-a mechanism contributing to metastasis. Oncogene 2007; 26: 2997-3005. (Pubitemid 46733648)
20. Nakata B, Fukunaga S, Noda E, Amano R, Yamada N, Hirakawa K,. Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer. Oncology 2008; 74: 69-75. (Pubitemid 351915012)
21. Alfonso-Perez M, Lopez-Giral S, Quintana NE, Loscertales J, Martin-Jimenez P, Munoz C,. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia. J Leukoc Biol 2006; 79: 1157-65. (Pubitemid 44835549)
22. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT,. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 1998; 95: 258-63. (Pubitemid 28103941)
23. MartIn-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F,. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 2003; 198: 615-21. (Pubitemid 37040395)
24. Sugaya M, Fang L, Cardones AR, Kakinuma T, Jaber SH, Blauvelt A, Hwang ST,. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J Immunol 2006; 177: 7665-72. (Pubitemid 44846281)
25. Egberts JH, Cloosters V, Noack A, Schniewind B, Thon L, Klose S, Kettler B, von Forstner C, Kneitz C, Tepel J, Adam D, Wajant H, et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 2008; 68: 1443-50. (Pubitemid 351346852)